Kathryn E. Giusti
Fondatore presso The Multiple Myeloma Research Foundation, Inc.
Patrimonio netto: 47 816 $ in data 31/10/2023
Posizioni attive di Kathryn E. Giusti
Società | Posizione | Inizio | Fine |
---|---|---|---|
The Multiple Myeloma Research Foundation, Inc.
The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Multiple Myeloma Research Foundation, Inc. provides funding for research on myeloma treatment. It provides funding to laboratories worldwide, including compounds and approaches in clinical trials and pre-clinical studies. The firm also facilitates clinical trials through their affiliate organization, the Multiple Myeloma Research Consortium. The company was founded by Karen E. Andrews and Kathryn E. Giusti in 1998 and is headquartered in Norwalk, CT. | Direttore/Membro del Consiglio | 03/02/2016 | - |
Fondatore | 01/01/1998 | - | |
Amministratore Delegato | 01/01/1998 | 01/03/2014 | |
Presidente | 01/03/2014 | 03/02/2016 | |
Corporate Officer/Principal | - | - | |
EQRx International, Inc.
EQRx International, Inc. Pharmaceuticals: MajorHealth Technology EQRx International, Inc. engages in healthcare services. The firm specializes in remaking medicine services. The company was founded by Peter Bach and Sandra Horning on January 12, 2020 and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | 27/09/2021 | - |
Harvard Business School | Fondatore | 01/01/2016 | - |
FasterCures | Corporate Officer/Principal | - | - |
Storia della carriera di Kathryn E. Giusti
Precedenti posizioni note di Kathryn E. Giusti
Società | Posizione | Inizio | Fine |
---|---|---|---|
EQRX, INC. | Direttore/Membro del Consiglio | 01/09/2021 | 09/11/2023 |
Independent Dir/Board Member | 01/09/2021 | 09/11/2023 | |
G.D. Searle & Co., Inc.
G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Corporate Officer/Principal | 01/01/1992 | 01/03/1997 |
MERCK & CO., INC. | Corporate Officer/Principal | 01/01/1980 | 01/01/1983 |
Multiple Myeloma Research Consortium
Multiple Myeloma Research Consortium Miscellaneous Commercial ServicesCommercial Services Multiple Myeloma Research Foundation, the mission of the MMRF is to accelerate the development of novel and combination treatments for patients with multiple myeloma by promoting and facilitating collaborative research between industry and academia. The MMRC is led by an exceptional Leadership Team, including a full scientific and clinical staff, which is headquartered in Norwalk, Conn | Amministratore Delegato | 01/01/2004 | - |
Fondatore | 01/01/2004 | - | |
IMS HEALTH, INC. | Direttore/Membro del Consiglio | 01/02/2002 | - |
Formazione di Kathryn E. Giusti
University of Vermont | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 11 |
Posizioni
Director/Board Member | 4 |
Corporate Officer/Principal | 4 |
Founder | 3 |
Settori
Health Technology | 4 |
Commercial Services | 3 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
MERCK & CO., INC. | Health Technology |
EQRX, INC. | Health Technology |
Aziende private | 6 |
---|---|
IQVIA, Inc.
IQVIA, Inc. Data Processing ServicesTechnology Services IQVIA, Inc. provides information technology solutions to the healthcare industry. It offers research and development, enterprise information management, commercial analytics, market analysis, patient consent system, content management, and other related solutions. The company was founded by Bill Frohlich and David Dubow in 1954 and is headquartered in Danbury, CT. | Technology Services |
The Multiple Myeloma Research Foundation, Inc.
The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Multiple Myeloma Research Foundation, Inc. provides funding for research on myeloma treatment. It provides funding to laboratories worldwide, including compounds and approaches in clinical trials and pre-clinical studies. The firm also facilitates clinical trials through their affiliate organization, the Multiple Myeloma Research Consortium. The company was founded by Karen E. Andrews and Kathryn E. Giusti in 1998 and is headquartered in Norwalk, CT. | Commercial Services |
Multiple Myeloma Research Consortium
Multiple Myeloma Research Consortium Miscellaneous Commercial ServicesCommercial Services Multiple Myeloma Research Foundation, the mission of the MMRF is to accelerate the development of novel and combination treatments for patients with multiple myeloma by promoting and facilitating collaborative research between industry and academia. The MMRC is led by an exceptional Leadership Team, including a full scientific and clinical staff, which is headquartered in Norwalk, Conn | Commercial Services |
G.D. Searle & Co., Inc.
G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Process Industries |
EQRx International, Inc.
EQRx International, Inc. Pharmaceuticals: MajorHealth Technology EQRx International, Inc. engages in healthcare services. The firm specializes in remaking medicine services. The company was founded by Peter Bach and Sandra Horning on January 12, 2020 and is headquartered in Cambridge, MA. | Health Technology |
FasterCures |
- Borsa valori
- Insiders
- Kathryn E. Giusti
- Esperienza